Abstract:BackgroundThe metastatic cascade is a complex and multistep process with many potential barriers. Recently, miR-193a has been reported to be a suppressive miRNA in multiple types of cancers, but its underlying anti-oncogenic activity in non-small cell lung cancers (NSCLC) is not fully elucidated.MethodsThe expressions of miR-193a (miR-193a-5p) in human lung cancer tissues and cell lines were detected by real-time PCR. Dual-luciferase reporter assay was used to identify the direct target of miR-193a. Cell proliferation, apoptosis, and metastasis were assessed by CCK-8, flow cytometry, and Transwell assay, respectively.ResultsThe expression of miR-193a in lung cancer tissues was decreased comparing to adjacent non-tumor tissues due to DNA hypermethylation in lung cancer tissues. Ectopic expression of miR-193a inhibited cell proliferation, colony formation, migration, and invasion in A549 and H1299 cells. Moreover, overexpression of miR-193a partially reversed tumor growth factor-β1 (TGF-β1)-induced epithelial-to-mesenchymal transition (EMT) in NSCLC cells. Mechanistically, miR-193a reduced the expression of WT1, which negatively regulated the protein level of E-cadherin, suggesting that miR-193a might prevent EMT via modulating WT1-E-cadherin axis. Importantly, knockdown of WT1 resembled the anti-cancer activity by miR-193a and overexpression of WT1 partially reversed miR-193a-induced anti-cancer activity, indicating that WT1 plays an important role in miR-193a-induced anti-cancer activity. Finally, overexpression of miR-193a decreased the growth of tumor xenografts in mice.ConclusionCollectively, our results have revealed an important role of miR-193a-WT1-E-cadherin axis in metastasis, demonstrated an important molecular cue for EMT, and suggested a therapeutic strategy of restoring miR-193a expression in NSCLC.

Targeting Smad2 and Smad3 by Mir-136 Suppresses Metastasis-Associated Traits of Lung Adenocarcinoma Cells

MicroRNA-182 Targets SMAD7 to Potentiate TGFβ-induced Epithelial-Mesenchymal Transition and Metastasis of Cancer Cells.

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

MicroRNA-206 Inhibits the Viability and Migration of Human Lung Adenocarcinoma Cells Partly by Targeting MET.

Overexpression of Mir-30A in Lung Adenocarcinoma A549 Cell Line Inhibits Migration and Invasion Via Targeting EYA2.

MicroRNA-32-5p Inhibits Epithelial-Mesenchymal Transition and Metastasis in Lung Adenocarcinoma by Targeting SMAD Family 3.

Mir-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting Rhogdi1 and Alcam

Suppression of non-small cell lung cancer migration and invasion by hsa-miR-486-5p via the TGF-β/SMAD2 signaling pathway.

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

MiR‐182 Inhibits the Epithelial to Mesenchymal Transition and Metastasis of Lung Cancer Cells by Targeting the Met Gene

Mir-665 Inhibits Epithelial-to-mesenchymal Transition in Bladder Cancer Via the SMAD3/SNAIL Axis

CCT6A Suppresses SMAD2 and Promotes Prometastatic TGF-β Signaling

MicroRNA-145 Inhibits Lung Cancer Cell Metastasis.

The Mir-4732-5p/xpr1 Axis Suppresses the Invasion, Metastasis, and Epithelial–mesenchymal Transition of Lung Adenocarcinoma Via the PI3K/Akt/GSK3β/Snail Pathway

Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers

Inhibition mechanism of lung cancer cell metastasis through targeted regulation of Smad3 by miR-15a

MiR-937-3p Promotes Metastasis and Angiogenesis and is Activated by MYC in Lung Adenocarcinoma

Mir-940 Inhibits Tgf-Beta-Induced Epithelial-Mesenchymal Transition And Cell Invasion By Targeting Snail In Non-Small Cell Lung Cancer

MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.

MicroRNA-33b Inhibits Lung Adenocarcinoma Cell Growth, Invasion, and Epithelial-Mesenchymal Transition by Suppressing Wnt/β-catenin/ZEB1 Signaling

MiR-205 Inhibits the Invasion and Migration of Esophageal Squamous Cell Carcinoma by Modulating SMAD1 Expression